Literature DB >> 21160662

Mucinous carcinoma in Crohn's disease originating in a fistulous tract.

Hugh J Freeman1, Tom Perry, Douglas L Webber, Silvia D Chang, Mong-Yang Loh.   

Abstract

Malignant disease, including mucinous carcinomas of the colorectum, may complicate long-standing Crohn's disease. An 18-year-old male with extensive small and large bowel involvement with Crohn's disease developed recurrent peri-rectal fistulous disease that persisted for more than a decade despite pharmacological and surgical therapy as well as later therapy with biological agents. Eventually, an extensive and difficult-to-detect mucinous carcinoma developed in the fistulous tract. Although fistula cancer is rarely described in Crohn's disease, use of immunosuppressant and biological agents may play an initiating or exacerbating role in its development or progression. As potent biological agents are frequently used, often to avoid surgical treatment, clinicians should have an increasingly high index of suspicion for this potential complication, especially if fistulous drainage persists and remains refractory to medical therapy.

Entities:  

Keywords:  Adalimumab; Anal fistula; Anorectal adenocarcinoma; Crohn’s disease; Fistula carcinoma; Infliximab; Tumor necrosis factor antibodies

Year:  2010        PMID: 21160662      PMCID: PMC2999135          DOI: 10.4251/wjgo.v2.i7.307

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  26 in total

1.  Closing fistulas in Crohn's disease--should the accent be on maintenance or safety?

Authors:  Claudio Fiocchi
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

2.  A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

Authors:  S R Targan; S B Hanauer; S J van Deventer; L Mayer; D H Present; T Braakman; K L DeWoody; T F Schaible; P J Rutgeerts
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

3.  Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease.

Authors:  Meena Thayu; Jonathan E Markowitz; Petar Mamula; Pierre A Russo; William I Muinos; Robert N Baldassano
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-02       Impact factor: 2.839

4.  Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease.

Authors:  Ann Corken Mackey; Lanh Green; Li-Ching Liang; Patricia Dinndorf; Mark Avigan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-02       Impact factor: 2.839

5.  Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy.

Authors:  Amer Zeidan; Ronald Sham; Joel Shapiro; Anthony Baratta; Peter Kouides
Journal:  Leuk Lymphoma       Date:  2007-07

6.  Development of adenocarcinoma in chronic fistula in Crohn's disease.

Authors:  S Laurent; A Barbeaux; B Detroz; O Detry; E Louis; J Belaiche; M Meurisse
Journal:  Acta Gastroenterol Belg       Date:  2005 Jan-Mar       Impact factor: 1.316

7.  Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study.

Authors:  L Biancone; A Orlando; A Kohn; E Colombo; R Sostegni; E Angelucci; F Rizzello; F Castiglione; L Benazzato; C Papi; G Meucci; G Riegler; C Petruzziello; F Mocciaro; A Geremia; E Calabrese; M Cottone; F Pallone
Journal:  Gut       Date:  2005-08-24       Impact factor: 23.059

8.  Colorectal cancer complicating Crohn's disease.

Authors:  H J Freeman
Journal:  Can J Gastroenterol       Date:  2001-04       Impact factor: 3.522

9.  Adenocarcinoma in perineal fistulas of Crohn's disease.

Authors:  A Chaikhouni; F I Regueyra; J R Stevens
Journal:  Dis Colon Rectum       Date:  1981 Nov-Dec       Impact factor: 4.585

10.  Appendiceal carcinoids in Crohn's disease.

Authors:  Hugh J Freeman
Journal:  Can J Gastroenterol       Date:  2003-01       Impact factor: 3.522

View more
  5 in total

1.  Mucinous adenocarcinoma arising from chronic perianal fistula mimicking horseshoe abscess.

Authors:  Surya Nandan Prasad; Abdul Razik; Farhana Siddiqui; Hira Lal
Journal:  BMJ Case Rep       Date:  2018-04-05

Review 2.  Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management.

Authors:  G Pellino; D S Keller; G M Sampietro; V Annese; M Carvello; V Celentano; C Coco; F Colombo; N Cracco; F Di Candido; M Franceschi; S Laureti; G Mattioli; L Pio; G Sciaudone; G Sica; V Villanacci; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-01-25       Impact factor: 3.781

3.  Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease.

Authors:  Britta Siegmund; Roger M Feakins; Giorgos Barmias; Juliano Coelho Ludvig; Fabio Vieira Teixeira; Gerhard Rogler; Michael Scharl
Journal:  J Crohns Colitis       Date:  2015-12-17       Impact factor: 9.071

4.  Mucinous adenocarcinoma in perianal fistula in Crohn's disease: Case report and literature review.

Authors:  Ana Beatriz Pereira de Souza; Amanda Pereira Lima; Lívia Moreira Genaro; Carla Peres Fingerhut Geiger; Maria de Lourdes Setsuko Ayrizono; Raquel Franco Leal
Journal:  Int J Surg Case Rep       Date:  2022-05-18

5.  Adenocarcinoma in an ano-vaginal fistula in Crohn's disease.

Authors:  Maryam Alfa-Wali; Angela Atinga; Yasser Mohsen; Andrew Anthony; Alistair Myers
Journal:  Int J Surg Case Rep       Date:  2013-04-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.